Literature DB >> 23838601

Large copy number variations in combination with point mutations in the TYMP and SCO2 genes found in two patients with mitochondrial disorders.

Alžběta Vondráčková1, Kateřina Veselá1, Hana Kratochvílová1, Vendula Kučerová Vidrová1, Kamila Vinšová1, Viktor Stránecký2, Tomáš Honzík1, Hana Hansíková1, Jiří Zeman1, Markéta Tesařová1.   

Abstract

Mitochondrial disorders are caused by defects in mitochondrial or nuclear DNA. Although the existence of large deletions in mitochondrial DNA (mtDNA) is well known, deletions affecting whole genes are not commonly described in patients with mitochondrial disorders. Based on the results of whole-genome analyses, copy number variations (CNVs) occur frequently in the human genome and may overlap with many genes associated with clinical phenotypes. We report the discovery of two large heterozygous CNVs on 22q13.33 in two patients with mitochondrial disorders. The first patient harboured a novel point mutation c.667G>A (p.D223N) in the SCO2 gene in combination with a paternally inherited 87-kb deletion. As hypertrophic cardiomyopathy (HCMP) was not documented in the patient, this observation prompted us to compare his clinical features with all 44 reported SCO2 patients in the literature. Surprisingly, the review shows that HCMP was present in only about 50% of the SCO2 patients with non-neonatal onset. In the second patient, who had mitochondrial neurogastrointestinal encephalopathy (MNGIE), a maternally inherited 175-kb deletion and the paternally inherited point mutation c.261G>T (p.E87D) in the TYMP gene were identified.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23838601      PMCID: PMC3925276          DOI: 10.1038/ejhg.2013.148

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  21 in total

Review 1.  The epidemiology of mitochondrial disorders--past, present and future.

Authors:  Andrew M Schaefer; Robert W Taylor; Douglass M Turnbull; Patrick F Chinnery
Journal:  Biochim Biophys Acta       Date:  2004-12-06

2.  Tissue-specific cytochrome c oxidase assembly defects due to mutations in SCO2 and SURF1.

Authors:  Lukas Stiburek; Katerina Vesela; Hana Hansikova; Petr Pecina; Marketa Tesarova; Leona Cerna; Josef Houstek; Jiri Zeman
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

3.  Thymidine phosphorylase gene mutations in patients with mitochondrial neurogastrointestinal encephalomyopathy syndrome.

Authors:  A Slama; C Lacroix; V Plante-Bordeneuve; A Lombès; M Conti; J M Reimund; E Auxenfants; P Crenn; P Laforêt; A Joannard; D Seguy; H Pillant; P Joly; S Haut; B Messing; G Said; A Legrand; A Guiochon-Mantel
Journal:  Mol Genet Metab       Date:  2005-01-24       Impact factor: 4.797

4.  A hemizygous SCO2 mutation in an early onset rapidly progressive, fatal cardiomyopathy.

Authors:  Scot C Leary; Andre Mattman; Timothy Wai; David C Koehn; Lorne A Clarke; Suzanne Chan; Brenda Lomax; Patrice Eydoux; Hilary D Vallance; Eric A Shoubridge
Journal:  Mol Genet Metab       Date:  2006-06-09       Impact factor: 4.797

5.  Targeted array CGH as a valuable molecular diagnostic approach: experience in the diagnosis of mitochondrial and metabolic disorders.

Authors:  Jing Wang; Hongli Zhan; Fang-Yuan Li; Amber N Pursley; Eric S Schmitt; Lee-Jun Wong
Journal:  Mol Genet Metab       Date:  2012-03-21       Impact factor: 4.797

6.  A new congenital muscular dystrophy with mitochondrial structural abnormalities.

Authors:  I Nishino; O Kobayashi; Y Goto; M Kurihara; K Kumagai; T Fujita; K Hashimoto; S Horai; I Nonaka
Journal:  Muscle Nerve       Date:  1998-01       Impact factor: 3.217

7.  A structural characterization of human SCO2.

Authors:  Lucia Banci; Ivano Bertini; Simone Ciofi-Baffoni; Ioannis P Gerothanassis; Iliana Leontari; Manuele Martinelli; Shenlin Wang
Journal:  Structure       Date:  2007-09       Impact factor: 5.006

Review 8.  Challenges and standards in integrating surveys of structural variation.

Authors:  Stephen W Scherer; Charles Lee; Ewan Birney; David M Altshuler; Evan E Eichler; Nigel P Carter; Matthew E Hurles; Lars Feuk
Journal:  Nat Genet       Date:  2007-07       Impact factor: 38.330

9.  Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency.

Authors:  Yutaka Nishigaki; Ramon Martí; William C Copeland; Michio Hirano
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

10.  Mitochondrial DNA background modulates the assembly kinetics of OXPHOS complexes in a cellular model of mitochondrial disease.

Authors:  Rosa Pello; Miguel A Martín; Valerio Carelli; Leo G Nijtmans; Alessandro Achilli; Maria Pala; Antonio Torroni; Aurora Gómez-Durán; Eduardo Ruiz-Pesini; Andrea Martinuzzi; Jan A Smeitink; Joaquín Arenas; Cristina Ugalde
Journal:  Hum Mol Genet       Date:  2008-09-19       Impact factor: 6.150

View more
  4 in total

Review 1.  Mitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So Far.

Authors:  Dario Pacitti; Michelle Levene; Caterina Garone; Niranjanan Nirmalananthan; Bridget E Bax
Journal:  Front Genet       Date:  2018-12-21       Impact factor: 4.599

Review 2.  Susceptible loci associated with autoimmune disease as potential biomarkers for checkpoint inhibitor-induced immune-related adverse events.

Authors:  Esmée P Hoefsmit; Elisa A Rozeman; John B A G Haanen; Christian U Blank
Journal:  ESMO Open       Date:  2019-07-21

3.  Mitochondrial Dysfunction may explain symptom variation in Phelan-McDermid Syndrome.

Authors:  Richard E Frye; Devin Cox; John Slattery; Marie Tippett; Stephen Kahler; Doreen Granpeesheh; Shirish Damle; Agustin Legido; Michael J Goldenthal
Journal:  Sci Rep       Date:  2016-01-29       Impact factor: 4.379

4.  Mitochondrial neurogastrointestinal encephalomyopathy: approaches to diagnosis and treatment.

Authors:  Bridget E Bax
Journal:  J Transl Genet Genom       Date:  2020-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.